{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:18:46Z","timestamp":1768771126516,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11936-019-0730-7","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:53:52Z","timestamp":1558176832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transcatheter Tricuspid Valve Therapy"],"prefix":"10.1007","volume":"21","author":[{"given":"Dhaval","family":"Kolte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fcvm.2018.00129","volume":"5","author":"OM Demir","year":"2018","unstructured":"Demir OM, Regazzoli D, Mangieri A, Ancona MB, Mitomo S, Weisz G, et al. Transcatheter tricuspid valve replacement: principles and design. Front Cardiovasc Med. 2018;5:129. \n                      https:\/\/doi.org\/10.3389\/fcvm.2018.00129\n                      \n                    .","journal-title":"Front Cardiovasc Med"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","volume":"83","author":"JP Singh","year":"1999","unstructured":"Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83:897\u2013902.","journal-title":"Am J Cardiol"},{"issue":"3","key":"730_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Yan Topilsky","year":"2019","unstructured":"Topilsky Y, Maltais S, Medina IJ, Oguz D, Michelena H, Maalouf J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2018. \n                      https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.014\n                      \n                    .","journal-title":"JACC: Cardiovascular Imaging"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2003.09.036\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jtcvs.2006.08.049","volume":"132","author":"O Stuge","year":"2006","unstructured":"Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg. 2006;132:1258\u201361. \n                      https:\/\/doi.org\/10.1016\/j.jtcvs.2006.08.049\n                      \n                    .","journal-title":"J Thorac Cardiovasc Surg"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jtcvs.2011.07.004","volume":"143","author":"CM Vassileva","year":"2012","unstructured":"Vassileva CM, Shabosky J, Boley T, Markwell S, Hazelrigg S. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg. 2012;143:1043\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jtcvs.2011.07.004\n                      \n                    .","journal-title":"J Thorac Cardiovasc Surg"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jtcvs.2012.04.019","volume":"146","author":"JB Kim","year":"2013","unstructured":"Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation. J Thorac Cardiovasc Surg. 2013;146:278\u201384. \n                      https:\/\/doi.org\/10.1016\/j.jtcvs.2012.04.019\n                      \n                    .","journal-title":"J Thorac Cardiovasc Surg"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.amjcard.2006.03.047","volume":"98","author":"DA Kwon","year":"2006","unstructured":"Kwon DA, Park JS, Chang HJ, Kim YJ, Sohn DW, Kim KB, et al. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am J Cardiol. 2006;98:659\u201361. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2006.03.047\n                      \n                    .","journal-title":"Am J Cardiol"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.jacc.2016.01.063","volume":"67","author":"J Rodes-Cabau","year":"2016","unstructured":"Rodes-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67:1829\u201345. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2016.01.063\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"730_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcin.2018.10.022","volume":"12","author":"Maurizio Taramasso","year":"2019","unstructured":"\u2022\u2022 Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, et al. Outcomes after current Transcatheter tricuspid valve intervention: mid-term results from the international TriValve Registry. JACC Cardiovasc Interv. 2018. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2018.10.022\n                      \n                    . This article describes the 30-day and 6-month outcomes of patients enrolled in a large, prospective international registry to evaluate the clinical applications of transcatheter tricuspid valve intervention with different devices.","journal-title":"JACC: Cardiovascular Interventions"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.jcin.2018.05.049","volume":"11","author":"D Braun","year":"2018","unstructured":"Braun D, Orban M, Orban M, Hagl C, Massberg S, Nabauer M, et al. Transcatheter edge-to-edge repair for severe tricuspid regurgitation using the triple-orifice technique versus the bicuspidalization technique. JACC Cardiovasc Interv. 2018;11:1790\u20132. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2018.05.049\n                      \n                    .","journal-title":"JACC Cardiovasc Interv"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.116.024848","volume":"135","author":"G Nickenig","year":"2017","unstructured":"Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135:1802\u201314. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024848\n                      \n                    .","journal-title":"Circulation"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ejhf.1147","volume":"20","author":"M Orban","year":"2018","unstructured":"Orban M, Besler C, Braun D, Nabauer M, Zimmer M, Orban M, et al. Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Eur J Heart Fail. 2018;20:1055\u201362. \n                      https:\/\/doi.org\/10.1002\/ejhf.1147\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.4244\/EIJ-D-18-00186","volume":"14","author":"D Braun","year":"2018","unstructured":"Braun D, Nabauer M, Orban M, Englmaier A, Rosler D, Hagl C, et al. One-year results of transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention. 2018;14:e413\u20135. \n                      https:\/\/doi.org\/10.4244\/EIJ-D-18-00186\n                      \n                    .","journal-title":"EuroIntervention"},{"key":"730_CR15","unstructured":"NCT03227757 Evaluation of Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE). C . 12-18-2018. 1-18-2019."},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(17)31600-8","volume":"390","author":"F Praz","year":"2017","unstructured":"Praz F, Spargias K, Chrissoheris M, Bullesfeld L, Nickenig G, Deuschl F, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017;390:773\u201380. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(17)31600-8\n                      \n                    .","journal-title":"Lancet"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcin.2017.12.004","volume":"11","author":"NP Fam","year":"2018","unstructured":"Fam NP, Ho EC, Zahrani M, Samargandy S, Connelly KA. Transcatheter tricuspid valve repair with the PASCAL system. JACC Cardiovasc Interv. 2018;11:407\u20138. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2017.12.004\n                      \n                    .","journal-title":"JACC Cardiovasc Interv"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.iccl.2017.08.007","volume":"7","author":"R Puri","year":"2018","unstructured":"Puri R, Rodes-Cabau J. The FORMA repair system. Interv Cardiol Clin. 2018;7:47\u201355. \n                      https:\/\/doi.org\/10.1016\/j.iccl.2017.08.007\n                      \n                    .","journal-title":"Interv Cardiol Clin"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jcin.2017.06.036","volume":"10","author":"G Perlman","year":"2017","unstructured":"\u2022 Perlman G, Praz F, Puri R, Ofek H, Ye J, Philippon F, et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv. 2017;10:1994\u20132003. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2017.06.036\n                      \n                    . This multicenter study reports the 1-year clinical and echocardiographic outcomes of 18 patients treated with the FORMA system.","journal-title":"JACC Cardiovasc Interv"},{"key":"730_CR20","unstructured":"NCT02471807. Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System. 3-22-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-18-2019."},{"key":"730_CR21","unstructured":"NCT02787408. The SPACER trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System. 12-26-2017. \n                      ClinicalTrials.gov\n                      \n                    . 1-18-2019."},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jacc.2015.01.025","volume":"65","author":"J Schofer","year":"2015","unstructured":"Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015;65:1190\u20135. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2015.01.025\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00000658-196507000-00009","volume":"162","author":"JH Kay","year":"1965","unstructured":"Kay JH, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162:53\u20138.","journal-title":"Ann Surg"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jtcvs.2006.08.068","volume":"133","author":"RK Ghanta","year":"2007","unstructured":"Ghanta RK, Chen R, Narayanasamy N, McGurk S, Lipsitz S, Chen FY, et al. Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg. 2007;133:117\u201326. \n                      https:\/\/doi.org\/10.1016\/j.jtcvs.2006.08.068\n                      \n                    .","journal-title":"J Thorac Cardiovasc Surg"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.15420\/icr.2017:21:1","volume":"13","author":"C Besler","year":"2018","unstructured":"Besler C, Meduri CU, Lurz P. Transcatheter treatment of functional tricuspid regurgitation using the Trialign device. Interv Cardiol. 2018;13:8\u201313. \n                      https:\/\/doi.org\/10.15420\/icr.2017:21:1\n                      \n                    .","journal-title":"Interv Cardiol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jacc.2017.01.054","volume":"69","author":"RT Hahn","year":"2017","unstructured":"\u2022 Hahn RT, Meduri CU, Davidson CJ, Lim S, Nazif TM, Ricciardi MJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol. 2017;69:1795\u2013806. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2017.01.054\n                      \n                    . This prospective, single-arm, multicenter, early feasibility study reports the 30-day outcomes of 15 patients treated with the Trialign device.","journal-title":"J Am Coll Cardiol"},{"key":"730_CR27","unstructured":"NCT03225612. Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) (SCOUT-II). 2-7-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-18-2019."},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.iccl.2017.08.006","volume":"7","author":"A Mangieri","year":"2018","unstructured":"Mangieri A, Lim S, Rogers JH, Latib A. Percutaneous tricuspid annuloplasty. Interv Cardiol Clin. 2018;7:31\u20136. \n                      https:\/\/doi.org\/10.1016\/j.iccl.2017.08.006\n                      \n                    .","journal-title":"Interv Cardiol Clin"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"Y110","DOI":"10.4244\/EIJV12SYA30","volume":"12","author":"BA Rosser","year":"2016","unstructured":"Rosser BA, Taramasso M, Maisano F. Transcatheter interventions for tricuspid regurgitation: TriCinch (4Tech). EuroIntervention. 2016;12:Y110\u20132. \n                      https:\/\/doi.org\/10.4244\/EIJV12SYA30\n                      \n                    .","journal-title":"EuroIntervention"},{"key":"730_CR30","unstructured":"NCT02098200. Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System\u2122 (PREVENT). 3-14-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-18-2019."},{"issue":"5","key":"730_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/eurheartj\/ehy424","volume":"40","author":"David Messika-Zeitoun","year":"2018","unstructured":"Messika-Zeitoun D, Nickenig G, Latib A, Kuck KH, Baldus S, Schueler R, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2018. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehy424\n                      \n                    .","journal-title":"European Heart Journal"},{"key":"730_CR32","unstructured":"Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy. 4-30-2018. Irvine, CA, Edwards Lifesciences, Inc. 1-18-2019."},{"key":"730_CR33","unstructured":"Nickenig G. TRI-REPAIR: 30-day outcomes of transcatheter TV repair in patients with severe secondary tricuspid regurgitation. Transcatheter Cardiovascular Therapeutics 2017. 11-2-2017. Denver, CO. 11\u20132\u20132017."},{"key":"730_CR34","unstructured":"NCT03382457. Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study. 8-15-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-19-2019."},{"key":"730_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.21037\/acs.2018.10.05","volume":"7","author":"JH Rogers","year":"2018","unstructured":"Rogers JH, Boyd WD, Smith TW, Bolling SF. Early experience with Millipede IRIS transcatheter mitral annuloplasty. Ann Cardiothorac Surg. 2018;7:780\u20136. \n                      https:\/\/doi.org\/10.21037\/acs.2018.10.05\n                      \n                    .","journal-title":"Ann Cardiothorac Surg"},{"key":"730_CR36","unstructured":"First Clinical Tricuspid Bicuspidization Procedure Completed Using Micro Interventional Devices\u2019 MIA Technology. Cardiac Interventions TODAY. 09-07-2017. \n                      https:\/\/citoday.com\/2017\/09\/11\/first-clinical-tricuspid-bicuspidization-procedure-completed-using-micro-interventional-devices-mia-technology?center=22\n                      \n                    . 1-18-2019."},{"key":"730_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jcin.2014.10.013","volume":"8","author":"T Rogers","year":"2015","unstructured":"Rogers T, Ratnayaka K, Sonmez M, Franson DN, Schenke WH, Mazal JR, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8:483\u201391. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2014.10.013\n                      \n                    .","journal-title":"JACC Cardiovasc Interv"},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"E175","DOI":"10.1002\/ccd.27531","volume":"92","author":"JM Khan","year":"2018","unstructured":"Khan JM, Rogers T, Schenke WH, Greenbaum AB, Babaliaros VC, Paone G, et al. Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve. Catheter Cardiovasc Interv. 2018;92:E175\u201384. \n                      https:\/\/doi.org\/10.1002\/ccd.27531\n                      \n                    .","journal-title":"Catheter Cardiovasc Interv"},{"key":"730_CR39","first-page":"66","volume":"25","author":"R Hetzer","year":"2016","unstructured":"Hetzer R, Javier M, Delmo Walter EM. The double-orifice valve technique to treat tricuspid valve incompetence. J Heart Valve Dis. 2016;25:66\u201371.","journal-title":"J Heart Valve Dis"},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcin.2016.10.036","volume":"10","author":"J Aboulhosn","year":"2017","unstructured":"Aboulhosn J, Cabalka AK, Levi DS, Himbert D, Testa L, Latib A, et al. Transcatheter valve-in-ring implantation for the treatment of residual or recurrent tricuspid valve dysfunction after prior surgical repair. JACC Cardiovasc Interv. 2017;10:53\u201363. \n                      https:\/\/doi.org\/10.1016\/j.jcin.2016.10.036\n                      \n                    .","journal-title":"JACC Cardiovasc Interv"},{"key":"730_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jacc.2018.10.051","volume":"73","author":"DB McElhinney","year":"2019","unstructured":"\u2022\u2022 McElhinney DB, Aboulhosn JA, Dvir D, Whisenant B, Zhang Y, Eicken A, et al. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019;73:148\u201357. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2018.10.051\n                      \n                    . This article reports the 3-year outcomes (death, reintervention, and valve-related adverse outcomes) of 306 patients enrolled in the Valve-in-Valve International Database (VIVID) Registry who underwent transcatheter tricuspid valve-in-valve or valve-in-ring replacement.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"730_CR42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jcmg.2018.08.034","volume":"12","author":"Rebecca T. Hahn","year":"2019","unstructured":"Hahn RT, George I, Kodali SK, Nazif T, Khalique OK, Akkoc D, et al. Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging. 2018. \n                      https:\/\/doi.org\/10.1016\/j.jcmg.2018.08.034\n                      \n                    .","journal-title":"JACC: Cardiovascular Imaging"},{"key":"730_CR43","doi-asserted-by":"publisher","unstructured":"Navia JL, Kapadia S, Elgharably H, Harb SC, Krishnaswamy A, Unai S, et al. First-in-human implantations of the NaviGate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ Cardiovasc Interv. 2017;10. \n                      https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005840\n                      \n                    .","DOI":"10.1161\/CIRCINTERVENTIONS.117.005840"},{"issue":"4","key":"730_CR44","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jcmg.2018.11.017","volume":"12","author":"Mara Gavazzoni","year":"2019","unstructured":"Gavazzoni M, Pozzoli A, Zuber M, Ho EC, Tanner FC, Kapos I, et al. Single-center experience with catheter-based tricuspid valve replacement for tricuspid regurgitation: procedural and echocardiographic findings. JACC Cardiovasc Imaging. 2019. \n                      https:\/\/doi.org\/10.1016\/j.jcmg.2018.11.017\n                      \n                    .","journal-title":"JACC: Cardiovascular Imaging"},{"key":"730_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fcvm.2018.00129","volume":"5","author":"OM Demir","year":"2018","unstructured":"Demir OM, Regazzoli D, Mangieri A, Ancona MB, Mitomo S, Weisz G, et al. Transcatheter tricuspid valve replacement: principles and design. Front Cardiovasc Med. 2018;5:129. \n                      https:\/\/doi.org\/10.3389\/fcvm.2018.00129\n                      \n                    .","journal-title":"Front Cardiovasc Med"},{"key":"730_CR46","unstructured":"Weisz G (2018) TRISOL tricuspid valve replacement: a comprehensive solution for tricuspid regurgitation and RV dysfunction. The Structural Heart Diseas Summit 2018. 6-27-2018."},{"key":"730_CR47","doi-asserted-by":"publisher","first-page":"B38","DOI":"10.1016\/j.jacc.2017.09.143","volume":"70","author":"F Lu","year":"2017","unstructured":"Lu F, Xu Z, Cao P, Chen Z, Lv S, Song Z. TCT-88 catheter-based tricuspid valve replacement via right atrium: an animal experimental study (abstr). J Am Coll Cardiol. 2017;70:B38\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/eurheartj\/ehr028","volume":"32","author":"A Lauten","year":"2011","unstructured":"Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32:1207\u201313. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehr028\n                      \n                    .","journal-title":"Eur Heart J"},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"e006061","DOI":"10.1161\/CIRCINTERVENTIONS.117.006061","volume":"11","author":"A Lauten","year":"2018","unstructured":"Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv. 2018;11:e006061. \n                      https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.006061\n                      \n                    .","journal-title":"Circ Cardiovasc Interv"},{"key":"730_CR50","doi-asserted-by":"publisher","first-page":"Y116","DOI":"10.4244\/EIJV12SYA32","volume":"12","author":"HR Figulla","year":"2016","unstructured":"Figulla HR, Kiss K, Lauten A. Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve. EuroIntervention. 2016;12:Y116\u20138. \n                      https:\/\/doi.org\/10.4244\/EIJV12SYA32\n                      \n                    .","journal-title":"EuroIntervention"},{"key":"730_CR51","unstructured":"NCT02339974 Heterotopic implantation of the Edwards-Sapien transcatheter aortic valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER). 12-7-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-20-2019."},{"key":"730_CR52","unstructured":"NCT02387697 Treatment of severe secondary TRIcuspid regurgitation in patients with advance heart failure with CAval vein implantation of the Edwards Sapien XT VALve (TRICAVAL). 9-18-2018. \n                      ClinicalTrials.gov\n                      \n                    . 1-20-2019."}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-019-0730-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:55:36Z","timestamp":1589673336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-019-0730-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s11936-019-0730-7","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"18 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dhaval Kolte declares no potential conflicts of interest. Sammy Elmariah reports a grant from Edwards Lifesciences and personal fees from AstraZeneca and Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"26"}}